<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01058564</url>
  </required_header>
  <id_info>
    <org_study_id>1709</org_study_id>
    <nct_id>NCT01058564</nct_id>
  </id_info>
  <brief_title>A Prospective Evaluation of the Torax Medical Inc. Magnetic Esophageal Sphincter</brief_title>
  <official_title>A Prospective Evaluation of the Torax Medical Inc. Magnetic Esophageal Sphincter</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Torax Medical Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Torax Medical Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate a novel method of augmenting a weak Lower Esophageal Sphincter (LES).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is being conducted to evaluate a novel method of augmenting a weak Lower
      Esophageal Sphincter (LES) with a magnetic esophageal sphincter device.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prospective performance evaluation of the magnetic esophageal sphincter.</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">4</enrollment>
  <condition>Gastroesophageal Reflux Disease</condition>
  <arm_group>
    <arm_group_label>Implant device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Torax Medical, Inc. LINX Reflux Management System</intervention_name>
    <description>Implantable device, magnetic esophageal sphincter</description>
    <arm_group_label>Implant device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years, &lt;85 years, life expectancy &gt;3yrs.

          -  Documented history of GERD symptoms such as heartburn and regurgitation.

          -  On daily PPI treatment for at least 3-months.

          -  Partially responsive to PPI treatment.

          -  GERD symptoms, in absence of PPI therapy (minimum 10 days).

          -  Ambulatory Esophageal pH&lt;4 for ≥5% time or pH&lt;4 for ≥3% time in supine.

          -  Patient is a surgical candidate.

          -  Patient is able to understand and provide written informed consent.

          -  Patient is willing and able to cooperate with follow-up examinations.

        Exclusion Criteria:

          -  The procedure is an emergency procedure.

          -  Patient is currently being treated with another investigational drug or
             investigational mechanical support device.

          -  Prior Gastric or Esophageal Surgery.

          -  Any Endoscopic Intervention

          -  Suspected or confirmed Esophageal or Gastric Cancer.

          -  Hiatal Hernia ≥3cm by endoscopy

          -  Esophageal motility less than 30mmHg peristaltic amplitude on wet swallows and/or &gt;30%
             synchronous/repetitive waves.

          -  Esophagitis - Grade IV

          -  Barretts Esophagus.

          -  Gross obesity (BMI&gt;35).

          -  Symptoms of dysphagia or indications of dysphagia from esophagram.

          -  Patient has Scleroderma and/or Achalasia

          -  Gross esophageal anatomic abnormalities (obstructive lesions, significant strictures,
             etc)

          -  Patient cannot understand trial requirements or is unable to comply with follow-up
             schedule.

          -  Patient is pregnant or nursing, or plans to become pregnant.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Willem Bemelman, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Academisch Medisch Centrum (AMC)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Academisch Medisch Centrum</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2010</study_first_submitted>
  <study_first_submitted_qc>January 27, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2010</study_first_posted>
  <last_update_submitted>November 22, 2013</last_update_submitted>
  <last_update_submitted_qc>November 22, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>GERD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

